An increase in the manufacturing capacity of COVID vaccines in India has the potential to be a game-changer well beyond its borders, the US administration said.
“It’s important to us because India has suffered immensely from the outbreak. Virtually, no element of Indian society has been left untouched by this horrible scourge. That is why we have spoken of the focus on increased manufacturing in India,” US State Department spokesperson Ned Price told reporters.
“The increased manufacturing capacity in India, the volume of capacity has the potential to be a game-changer well beyond India’s borders. And that’s precisely why this arrangement was reached and announced in the context of the Quad,” he said.
In the last 24 hours, India logged 1,32,364 COVID infections and 2,713 people succumbed to the pandemic, the country’s Health and Family Welfare Ministry said.
On June 1, India reported 1,27,510 cases lowest since April 8. On April 8, India had recorded 1,31,968 cases while on April 7, the country witnessed 1,26,789 fresh cases.
Tamil Nadu was the largest contributor with almost 25,000 cases while in the metros the count in the last 24 hours was 487 in Delhi, 961 Mumbai, 3,533 in Bengaluru, 976 in Kolkata and 2,062 in Chennai.
India’s overall tally now stands at 2,85,74,350 with 16,35,993 active cases and 3,40,702 deaths so far.